Delisting risk
Soligenix
Develops rare-disease therapeutics and heat-stable biodefense vaccine candidates.
$0.3733
After-hours close−0.00 (−0.93%)
At close$0.3768(−0.84%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.12 | — | — |
| Aug 2026 | −$0.16 | −$0.12 | +22.6% |
| May 2026 | −$0.30 | −$0.28 | +6.7% |
| Apr 2026 | −$0.27 | $0.32 | +218.5% |
| Nov 2025 | −$0.63 | −$0.58 | +7.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | −$0.12 | — | — | — | — | — |
| Aug 7, 2026 | −$0.16 | −$0.12 | +22.6% | — | $0 | — |
| May 8, 2026 | −$0.30 | −$0.28 | +6.7% | — | — | — |
| Apr 3, 2026 | −$0.27 | $0.32 | +218.5% | — | — | — |
| Nov 7, 2025 | −$0.63 | −$0.58 | +7.9% | — | — | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 14, 2025 | ||||||
| May 9, 2025 | ||||||
| Mar 21, 2025 | ||||||
| Nov 8, 2024 | ||||||
| Aug 9, 2024 | ||||||
| May 10, 2024 | ||||||
| Mar 15, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Aug 21, 2023 | ||||||
| May 15, 2023 | ||||||
| Mar 31, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 12, 2022 | ||||||
| May 13, 2022 | ||||||
| Mar 29, 2022 | ||||||
| Nov 12, 2021 | ||||||
| Aug 13, 2021 | ||||||
| May 17, 2021 | ||||||
| Mar 30, 2021 | ||||||
| Nov 12, 2020 | ||||||
| Aug 14, 2020 | ||||||
| May 15, 2020 | ||||||
| Mar 30, 2020 | ||||||
| Nov 12, 2019 | ||||||
| Aug 13, 2019 | ||||||
| May 14, 2019 | ||||||
| Mar 26, 2019 | ||||||
| Nov 9, 2018 | ||||||
| Aug 8, 2018 | ||||||
| May 11, 2018 | ||||||
| Mar 15, 2018 | ||||||
| Nov 6, 2017 | ||||||
| Aug 11, 2017 | ||||||
| May 11, 2017 | ||||||
| Mar 27, 2017 | ||||||
| Nov 10, 2016 | ||||||
| Aug 11, 2016 | ||||||
| May 12, 2016 | ||||||
| Mar 24, 2016 | ||||||
| Nov 12, 2015 | ||||||
| Aug 12, 2015 | ||||||